Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.
about
Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory ConditionNeurovascular contributions to migraine: Moving beyond vasodilationModelling headache and migraine and its pharmacological manipulationDistribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosaceaNeurovascular and neuroimmune aspects in the pathophysiology of rosacea.Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models.Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.Pituitary adenylate cyclase-activating polypeptide (PACAP) signalling enhances osteogenesis in UMR-106 cell line.Pathogenesis and clinical presentation of rosacea as a key for a symptom-oriented therapy.Pathogenese und Klinik der Rosazea als Schlüssel für eine symptomorientierte Therapie.Neuroendocrinology of mast cells: Challenges and controversies.Characterization of the thermoregulatory response to pituitary adenylate cyclase-activating polypeptide in rodents.Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).The relationship between migraine and rosacea: Systematic review and meta-analysis.Pituitary adenylate cyclase-activating polypeptide promotes eccrine gland sweat secretion.PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma.Skin neurogenic inflammation.
P2860
Q28067747-1D2E55BB-F374-444B-8C46-71C005E2A1DFQ28392631-55032C8F-0895-4A29-BE2D-D5F2AECFDCD7Q34407137-496929EE-3C0A-4A9E-942D-7A0BD7E210C5Q35834762-A24223BC-22D7-4506-BD01-A72411D2D38AQ36992055-F21F6867-04E3-4BD3-AD06-C918026B1EA9Q37644437-8A10B136-9FAA-4053-9C6D-4CB5A851E3A9Q38885566-7A24E682-04CA-429D-A7D3-054237E138A0Q38967086-30894C06-8626-48B9-8064-95DB49B77DCFQ39015127-BDB0ACD2-4746-4C9D-BDE7-3793D60A5E13Q39015145-B0E2813E-4E7D-40DB-A521-A20D1E4D797DQ39091869-9C3F1742-D87C-45B0-B4DE-974F8616CA42Q40201264-321F825D-7D13-48BF-BE7A-1805A9D5E6FFQ47441037-FA76BB05-66E9-498A-BB57-AA8DAE31AD3BQ47944255-D2963ED2-9F77-4F05-AE44-A2703028A532Q47974930-165DFBB3-04FF-4E47-BB18-35E0119F647BQ52656846-CFD4C5A7-061D-4689-8975-7827AD0D7466Q54224167-F2E3B617-004D-4ED7-8E43-DAB6732491C4
P2860
Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pituitary adenylate cyclase ac ...... gulator in human skin in vivo.
@ast
Pituitary adenylate cyclase ac ...... gulator in human skin in vivo.
@en
Pituitary adenylate cyclase ac ...... gulator in human skin in vivo.
@nl
type
label
Pituitary adenylate cyclase ac ...... gulator in human skin in vivo.
@ast
Pituitary adenylate cyclase ac ...... gulator in human skin in vivo.
@en
Pituitary adenylate cyclase ac ...... gulator in human skin in vivo.
@nl
prefLabel
Pituitary adenylate cyclase ac ...... gulator in human skin in vivo.
@ast
Pituitary adenylate cyclase ac ...... gulator in human skin in vivo.
@en
Pituitary adenylate cyclase ac ...... gulator in human skin in vivo.
@nl
P2093
P2860
P50
P1476
Pituitary adenylate cyclase ac ...... egulator in human skin in vivo
@en
P2093
Anjona Schmidt-Choudhury
Carine Rosignoli
Dieter Metze
Johannes J Voegel
Jörg Buddenkotte
Roman Rukwied
Stephan Seeliger
Ulrike von Arnim
Victoria Shpacovitch
Wolfgang E Schmidt
P2860
P304
P356
10.2353/AJPATH.2010.090941
P407
P577
2010-10-01T00:00:00Z